Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.

Felger JC, Alagbe O, Pace TW, Woolwine BJ, Hu F, Raison CL, Miller AH.

Brain Behav Immun. 2011 Aug;25(6):1094-8. doi: 10.1016/j.bbi.2011.02.015. Epub 2011 Feb 26.

2.

Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.

Udina M, Moreno-España J, Navinés R, Giménez D, Langohr K, Gratacòs M, Capuron L, de la Torre R, Solà R, Martín-Santos R.

Psychoneuroendocrinology. 2013 Sep;38(9):1803-13. doi: 10.1016/j.psyneuen.2013.03.007. Epub 2013 Apr 6.

PMID:
23571152
3.

Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.

Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH.

Mol Psychiatry. 2010 May;15(5):535-47. doi: 10.1038/mp.2008.58. Epub 2008 Jun 3.

4.

IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.

Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH.

Brain Behav Immun. 2008 Aug;22(6):870-80. doi: 10.1016/j.bbi.2007.12.009. Epub 2008 Feb 6.

5.

Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.

Felger JC, Cole SW, Pace TW, Hu F, Woolwine BJ, Doho GH, Raison CL, Miller AH.

Psychol Med. 2012 Aug;42(8):1591-603. doi: 10.1017/S0033291711002868. Epub 2011 Dec 9.

6.

[Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].

Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.

Encephale. 2009 Oct;35(5):477-83. doi: 10.1016/j.encep.2007.09.007. Epub 2008 Jun 12. French.

PMID:
19853722
7.

Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR, Miller AH.

Biol Psychiatry. 2010 Nov 15;68(10):942-9. doi: 10.1016/j.biopsych.2010.04.019. Epub 2010 May 26.

8.

Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?

Kenis G, Prickaerts J, van Os J, Koek GH, Robaeys G, Steinbusch HW, Wichers M.

Int J Neuropsychopharmacol. 2011 Mar;14(2):247-53. doi: 10.1017/S1461145710000830. Epub 2010 Jul 29.

PMID:
20667172
9.

Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.

Felger JC, Haroon E, Woolwine BJ, Raison CL, Miller AH.

Physiol Behav. 2016 Nov 1;166:14-21. doi: 10.1016/j.physbeh.2015.12.013. Epub 2015 Dec 17.

10.

Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.

Frydecka D, Pawłowski T, Pawlak D, Małyszczak K.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):169-175. doi: 10.1007/s00005-016-0441-7. Epub 2017 Jan 12.

11.

Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells.

He SF, Wang W, Ren H, Zhao LJ, Qi ZT.

Cytokine. 2013 Mar;61(3):801-7. doi: 10.1016/j.cyto.2013.01.007. Epub 2013 Feb 12.

PMID:
23410505
12.

Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.

Comai S, Cavalletto L, Chemello L, Bernardinello E, Ragazzi E, Costa CV, Bertazzo A.

Pharmacol Res. 2011 Jan;63(1):85-92. doi: 10.1016/j.phrs.2010.10.009. Epub 2010 Oct 19.

PMID:
20940053
13.
14.

Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.

Maddock C, Landau S, Barry K, Maulayah P, Hotopf M, Cleare AJ, Norris S, Pariante CM.

Mol Psychiatry. 2005 Apr;10(4):332-3. No abstract available.

PMID:
15655564
15.

Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.

Mahajan S, Avasthi A, Grover S, Chawla YK.

J Psychosom Res. 2014 Aug;77(2):109-15. doi: 10.1016/j.jpsychores.2014.05.008. Epub 2014 Jun 2.

PMID:
25077851
16.

Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.

Schäfer A, Scheurlen M, Seufert J, Keicher C, Weissbrich B, Rieger P, Kraus MR.

J Hepatol. 2010 Jan;52(1):10-5. doi: 10.1016/j.jhep.2009.10.007. Epub 2009 Oct 21.

PMID:
19897271
17.

[Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].

Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Andrzej K.

Psychiatr Pol. 2006 Jul-Aug;40(4):799-808. Polish.

PMID:
17068951
18.

T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy.

Fathy A, Ahmed AS, Metwally L, Hassan A.

Med Princ Pract. 2011;20(4):345-9. doi: 10.1159/000323770. Epub 2011 May 11.

19.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

20.

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.

Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH.

Brain Behav Immun. 2005 Jan;19(1):23-7.

PMID:
15581735

Supplemental Content

Support Center